Ghent University Academic Bibliography

Your filters: cql: author="Dirix, Piet" or (type any "bookEditor issueEditor" and editor="Dirix, Piet")

Add to list
- Journal Article
- A1
- open access
Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer : a phase 2 trial : results of secondary endpoints

Flor Verghote (UGent) , Elke Rammant (UGent) , Piet Dirix, Charles Van Praet (UGent) , Charlien Berghen, Sara Junius, Nick Liefhooghe, Leen Noé, Piet Ost (UGent) , Karel Decaestecker (UGent) , et al.

(2025) EUROPEAN UROLOGY FOCUS.
Add to list
- Conference Paper
- C3
Adjuvant EBRT for muscle-invasive bladder cancer : phase 2 trial secondary analysis (NCT02397434)

Flor Verghote (UGent) , Piet Dirix, Charles Van Praet (UGent) , Charlien Berghen, Ben Vanneste (UGent) , Sara Junius, Nick Liefhooghe, Leen Noé, Gert De Meerleer, Piet Ost (UGent) , et al.

(2024) RADIOTHERAPY AND ONCOLOGY. In Radiotherapy and Oncology 194(Supplement 1). p.S2308-S2311
Add to list
- Journal Article
- A1
- open access
Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease : an interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study

Sebastian M. Christ, Filippo Alongi, Umberto Ricardi, Marta Scorsetti, Lorenzo Livi, Panagiotis Balermpas, Yolande Lievens (UGent) , Pètra Braam, Barbara Alicja Jereczek-Fossa, Karin Stellamans, et al.

(2024) RADIOTHERAPY AND ONCOLOGY. 195.
Add to list
PEACE V—Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM) : acute toxicity of a randomized phase 2 trial

Piet Ost (UGent) , Shankar Siva, Sigmund Brabrand, Piet Dirix, Nick Liefhooghe, François-Xavier Otte, Alfonso Gomez-Iturriaga, Wouter Everaerts, Mohamed Shelan, Antonio Conde-Moreno, et al.

(2024) EUROPEAN UROLOGY ONCOLOGY. 7(3). p.462-468
Add to list
- Journal Article
- A1
- open access
International consensus guidelines for adjuvant radiation therapy for bladder cancer after radical cystectomy : update from an IBIS workgroup

Flor Verghote (UGent) , Paul Sargos, John P. Christodouleas, Vedang Murthy, Brian C. Baumann, Piet Dirix, Charlien Berghen, Leen Paelinck (UGent) , Tom Vercauteren (UGent) and Valerie Fonteyne (UGent)

(2022) PRACTICAL RADIATION ONCOLOGY. 12(6). p.524-532
Add to list
Can medical imaging identify the histopathological growth patterns of liver metastases?

Emily Latacz, Pieter-Jan van Dam, Christian Vanhove (UGent) , Laura Llado, Benedicte Descamps (UGent) , Núria Ruiz, Ines Joye, Dirk Grünhagen, Steven Van Laere, Piet Dirix, et al.

(2021) SEMINARS IN CANCER BIOLOGY. 71. p.33-41
Add to list
- Conference Paper
- C3
Immuno-radiotherapy in solid tumors : preliminary results of the randomized phase 2 CHEERS trial

Mathieu Spaas (UGent) , Nora Sundahl, Sylvie Rottey (UGent) , VIBEKE KRUSE (UGent) , Daan De Maeseneer (UGent) , Fréderic Duprez (UGent) , Piet Dirix, Veerle Surmont (UGent) , Yolande Lievens (UGent) , Robin Van den Begin, et al.

(2021) ESTRO 2021, Abstracts. 161(S1). p.S490-S491
Add to list
- Journal Article
- A1
- open access
Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC) : a phase II prospective trial

Flor Verghote (UGent) , Lindsay Poppe (UGent) , Sofie Verbeke (UGent) , Piet Dirix, Maarten Albersen, Gert De Meerleer, Charlien Berghen, Piet Ost (UGent) , Geert Villeirs (UGent) , Pieter De Visschere (UGent) , et al.

(2021) BMC CANCER. 21(1).
Add to list
- Journal Article
- A1
- open access
Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS) : study protocol for a phase 2, open-label, randomized controlled trial

Mathieu Spaas (UGent) , Nora Sundahl, Eva Hulstaert, Vibeke Kruse (UGent) , Sylvie Rottey (UGent) , Daan De Maeseneer (UGent) , Veerle Surmont (UGent) , Annabel Meireson, Lieve Brochez (UGent) , Dries Reynders (UGent) , et al.

(2021) BMC CANCER. 21(1).
Add to list
- Miscellaneous
- open access
The multicenter, randomized, phase 2 PEACE V-STORM trial : defining the best salvage treatment for oligorecurrent nodal prostate cancer metastases

Thomas Zilli, Piet Dirix, Reino Heikkila, Nick Liefhooghe, Shankar Siva, Alfonso Gomez-Iturriaga, Wouter Everaerts, Francois Otte, Mohamed Shelan, Carole Mercier, et al.

(2021) EUROPEAN UROLOGY FOCUS. 7(2). p.241-244

Academic Bibliography

Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer : a phase 2 trial : results of secondary endpoints

Adjuvant EBRT for muscle-invasive bladder cancer : phase 2 trial secondary analysis (NCT02397434)

Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease : an interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study

PEACE V—Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM) : acute toxicity of a randomized phase 2 trial

International consensus guidelines for adjuvant radiation therapy for bladder cancer after radical cystectomy : update from an IBIS workgroup

Can medical imaging identify the histopathological growth patterns of liver metastases?

Immuno-radiotherapy in solid tumors : preliminary results of the randomized phase 2 CHEERS trial

Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC) : a phase II prospective trial

Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS) : study protocol for a phase 2, open-label, randomized controlled trial

The multicenter, randomized, phase 2 PEACE V-STORM trial : defining the best salvage treatment for oligorecurrent nodal prostate cancer metastases

Contents

Support

Contact